Paid Clinical Trials in DeSoto, TX

As of September 2026, 65 paid clinical trials are recruiting in DeSoto, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

60 clinical trials

Get a weekly email when new trials open in DeSoto, TX.

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

for Insomnia

Sites in DeSoto, Houston +11 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18 - 70

Code: NCT06655883·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for Major Depressive Disorder

Drug: NBI-1065845

Sites in DeSoto +11 more locations

Sponsor: Neurocrine Biosciences

Sex: All·Age: 18+

Code: NCT06911112·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for Schizophrenia

Drug: NBI-1117568

Sites in DeSoto, Austin +19 more locations

Sponsor: Neurocrine Biosciences

Sex: All·Age: 18 - 65

Code: NCT06963034·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

for Major Depressive Disorder (MDD)

Sites in DeSoto, Fort Worth +21 more locations

Sponsor: Draig Therapeutics Ltd

Sex: All·Age: 18 - 75

Code: NCT07610473·Phase 2·Recruiting·Listed May 2026

Apply to this trial

Radiprodil in Participants With Hepatic Impairment

for Hepatic Impairment

Sites in DeSoto & San Antonio

Sponsor: GRIN Therapeutics, Inc.

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07457229·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for Peripheral Artery Disease (PAD)

Sites in DeSoto, Plano +15 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07318610·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

for Heterozygous Familial Hypercholesterolemia

Sites in DeSoto +9 more locations

Sponsor: Verve Therapeutics, Inc.

Sex: All·Age: 18 - 70

Code: NCT06164730·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

for Schizophrenia

Sites in DeSoto +3 more locations

Sponsor: BioXcel Therapeutics Inc

Sex: All·Age: 10 - 17

Code: NCT05025605·Phase 1·Recruiting·Listed Aug 2021

Apply to this trial

Triage Survey for Psychiatry Research Eligibility

for Major Depressive Disorder

Sites in DeSoto +5 more locations

Sponsor: Adams Clinical

Sex: All·Age: 18+

Code: NCT05800925·Recruiting·Listed Apr 2023

Apply to this trial

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

for Obesity

Sites in DeSoto, Dallas +68 more locations

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07684235·Phase 3·Recruiting·Listed Jul 2026

Apply to this trial

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

for Schizophrenia

Sites in DeSoto, Richardson +40 more locations

Sponsor: MapLight Therapeutics

Sex: All·Age: 18 - 65

Code: NCT07459647·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

52-week Open Label Safety-Tolerability Study

for Schizophrenia

Sites in DeSoto, Richardson +21 more locations

Sponsor: LB Pharmaceuticals Inc.

Sex: All·Age: 18 - 65

Code: NCT07369154·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

for Graves Disease

Sites in DeSoto, Webster +9 more locations

Sponsor: Merida Biosciences

Sex: All·Age: 18 - 65

Code: NCT07305818·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for Non-alcoholic Fatty Liver Disease

Sites in DeSoto, Dallas +50 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 75

Code: NCT07221188·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for Non-alcoholic Fatty Liver Disease

Sites in DeSoto, Dallas +74 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 75

Code: NCT07221227·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in DeSoto, Dallas +40 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 75

Code: NCT07177339·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Sites in DeSoto, Dallas +308 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial